Skip to main content
. 2021 Aug 12;2(8):618–630. doi: 10.1302/2633-1462.28.BJO-2021-0092.R1

Table II.

Demographic data of the pooled cohort.

Variable Reported studies
(n = 112)
Shoulders with available data (n = 5,379) Result %
Mean age at revision, yrs (range) 105* 5,225 67 (21 to 84)
Mean follow-up, mths 107 3,609 48
Sex 101 4,862 Female 2,925/4,862 60
Male 1,910/4,862 40
Index surgery 100§ 3,295 Hemiarthroplasty 1,645/3,295 50
Anatomical TSA 1,152/3,295 35
Revere TSA 402/3,295 15
Revision surgery 109 5,004 Reverse TSA 3,341/5,004 67
Anatomical TSA 1,213/5,004 24
Hemiarthroplasty 348/5,004 7
Resection arthroplasty 43/5,004 <1
Antibiotic spacer implantation 41/5,004 <1
Indication for revision surgery 90** 3,041 Component loosening 601/3,041 20
Instability 577/3,041 19
Rotator cuff failure 528/3,041 17
Infection 490/3,041 16
Glenoid failure 401/3,041 13
Baseplate failure 83/3,041 3
Pain and stiffness 62/3,041 2
Fracture sequelae 59/3,041 2
Periprosthetic fracture 58/3,041 2
Tuberosity resorption 18/3,041 < 1
*

Age was not reported in seven studies. 20-26

Mean follow-up duration was not reported in four studies,23,27-29 all of which included cohorts followed up for longer than 24 months and one study19 included a cohort that was not followed up.

Sex of patients undergoing revision was not reported in 11 studies. 23-36,30-36

§

Index surgery was not reported in 12 studies. 19,24,26,28,37-44

Revision surgical procedure was not reported in three studies.26,41,42

**

Indication for revision surgery was not reported in 22 studies. 19,20,23,24,27,30,32,34-54,44-54

TSA, total shoulder arthroplasty.